STOCK TITAN

Cencora, Inc. Form 4 Filings

COR NYSE

Every Form 4 that Cencora, Inc. (COR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow COR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full COR filings page.

Rhea-AI Summary

Cencora, Inc. (COR) President & CEO and director Robert P. Mauch reported routine equity transactions. On 11/18/2025, he exercised a non-qualified stock option to acquire 3,763 shares of common stock at an exercise price of $86.09 per share. On the same date, he sold 5,096 shares of common stock at a price of $366.64 per share under a pre-arranged Rule 10b5-1 trading plan adopted on 11/15/2024.

After these transactions, Mauch directly beneficially owned 65,746 shares of Cencora common stock and held 11,288 derivative securities in the form of stock options. The option exercised on 11/18/2025 related to a grant that became exercisable in four equal installments on 11/13/2020, 11/13/2021, 11/13/2022 and 11/13/2023.

Rhea-AI Summary

Cencora (COR) reported insider equity activity by President & CEO and Director Robert P. Mauch. On 11/13/2025, he acquired 42,944 common shares at $0 upon satisfaction of performance share unit criteria, then had 18,677 shares withheld at $312.53 to cover taxes, resulting in 67,079 shares directly owned after these transactions. Separately, on 11/12/2025, he received a grant of 15,960 RSUs that vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028.

Rhea-AI Summary

Cencora (COR) reported insider activity by CFO James F. Cleary. On 11/13/2025, he acquired 30,062 shares of common stock at $0 upon satisfaction of performance share unit criteria, and 13,901 shares were withheld at $312.53 to satisfy tax obligations tied to that vesting. Following these transactions, he directly held 133,889.3479 shares.

Separately, on 11/12/2025, Cleary was granted 4,733 restricted stock units for no consideration. These RSUs vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028.

Rhea-AI Summary

Cencora (COR) reported an insider equity award. EVP, Chief Data & Info Officer Pawan Verma filed a Form 4 for a grant of 3,963 restricted stock units (RSUs) on 11/12/2025.

The RSUs were received for no consideration and vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028. Each RSU corresponds to one share of Cencora common stock, and the filing lists 3,963 derivative securities beneficially owned Direct (D) following the transaction.

Rhea-AI Summary

Cencora (COR) Executive Vice President Elizabeth S. Campbell filed a Form 4 disclosing equity changes. On 11/13/2025, she acquired 20,613 shares of common stock at $0 upon performance share unit vesting, and a same‑day withholding transaction covered taxes for 9,532 shares at $312.53.

Separately, on 11/12/2025 she received a grant of 3,523 RSUs that vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028. Following these transactions, she beneficially owned 26,388.141 shares, held directly.

Rhea-AI Summary

Cencora, Inc. (COR) reported insider equity activity by its SVP & Chief Accounting Officer, Lazarus Krikorian. On 11/13/2025, 2,434 shares of common stock were acquired at $0 upon meeting performance criteria, bringing direct holdings to 21,642 shares. The same day, 1,059 shares were disposed at $312.53 to satisfy tax withholding, resulting in 20,583 shares directly owned after the transactions.

In a separate equity grant, on 11/12/2025 the officer received 2,271 Restricted Stock Units at $0. These RSUs vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028.

Rhea-AI Summary

Cencora, Inc. (COR) reported insider equity changes for Executive Vice President Silvana Battaglia. On 11/13/2025, she acquired 12,885 shares of common stock at $0 upon the satisfaction of performance criteria tied to prior performance share units, and disposed of 5,612 shares at $312.53 to satisfy tax withholding related to that vesting. Following these transactions, she beneficially owns 19,947.464 common shares, held directly.

Separately, on 11/12/2025, she received a grant of 2,202 Restricted Stock Units at $0, which vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028.

Rhea-AI Summary

Cencora, Inc. (COR) reported insider activity by Executive Vice President Silvana Battaglia on 11/07/2025. Two restricted stock unit (RSU) tranches vested and were settled into common stock (codes M) for 1,265 shares and 1,084 shares. To cover tax withholding, she had broker-assisted sales (code F) of 551 shares and 473 shares at $360.70 per share. After these transactions, she directly owned 12,674.464 common shares.

The footnotes state the first RSU grant vested in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025, and the second RSU grant vests on 11/08/2024, 11/08/2025, and 11/08/2026. The 2023 grant is fully settled; 1,085 RSUs from the 2024 grant remain outstanding.

Rhea-AI Summary

Cencora (COR) reported insider activity by an Executive Vice President. On 11/07/2025, two restricted stock unit tranches converted to common stock: 2,023 shares and 1,830 shares (coded “M”). To cover taxes, the filer disposed of 798 shares and 572 shares at $360.7 per share (coded “F”). Following these transactions, directly beneficially owned common stock stood at 15,307.141 shares. The vesting schedules referenced cover installments on 11/09/2023–2025 and 11/08/2024–2026.

Rhea-AI Summary

Cencora (COR) reported a Form 4 for CFO James F. Cleary reflecting RSU vesting and tax withholding on 11/07/2025. Two RSU tranches converted to common stock: 2,951 shares and 2,439 shares (codes M). To satisfy withholding taxes, the company withheld and disposed of 1,250 shares and 705 shares at $360.7 per share (code F). Following these transactions, Cleary’s directly held common stock totaled 117,728.3479 shares.

The vested RSUs relate to grants scheduled to vest in equal annual installments on 11/9/2023–11/9/2025 and 11/08/2024–11/08/2026, as noted in the filing.

Rhea-AI Summary

Cencora (COR) reported insider activity by its SVP & Chief Accounting Officer. On 11/07/2025, two restricted stock unit (RSU) tranches vested and were settled into common stock: 1,433 shares and 1,398 shares (both at $0 exercise price).

To cover withholding taxes tied to the vesting, the insider disposed of 411 shares and 366 shares at $360.7 per share. Following these transactions, the insider directly holds 19,208 shares of common stock. The RSUs relate to grants vesting in equal annual installments on 11/09/2023–11/09/2025 and 11/08/2024–11/08/2026.

Rhea-AI Summary

Cencora, Inc. (COR) reported insider activity by President & CEO and Director Robert P. Mauch on 11/07/2025. Two restricted stock unit (RSU) tranches vested and were settled into common stock: 4,215 shares and 4,065 shares (codes M). To cover taxes upon vesting, the filer disposed of 1,735 shares and 1,673 shares at $360.70 per share (code F). After these transactions, Mauch directly beneficially owns 42,812 shares.

Footnotes indicate the RSUs were granted for no consideration and vest in three equal annual installments tied to November 2023–2026 dates.

Rhea-AI Summary

Cencora (COR) reported insider equity activity. On 10/31/2025, EVP and Chief Data & Info Officer Pawan Verma settled 8,537 restricted stock units into common stock (transaction code M). To satisfy tax withholding, 4,367 shares were disposed (transaction code F), both at a listed price of $337.81 per share. After these transactions, Verma directly owned 4,184.05 shares.

Rhea-AI Summary

Cencora (COR) reported an insider equity grant. Director Werner Baumann acquired 108 shares of common stock on 11/01/2025, shown at $337.81 per share, bringing his directly held balance to 3,130 shares.

The filing notes this was a grant of restricted stock units in lieu of a $36,250 quarterly cash retainer under the company’s Non‑Employee Director Compensation Program, with delivery of shares deferred until 02/15/2028.

Rhea-AI Summary

Cencora (COR) reported an insider transaction by a director. On 11/01/2025, the director acquired 89 shares of common stock at $337.81 per share. Following this transaction, beneficial ownership stands at 3,069 shares, held directly.

The filing notes the shares reflect a grant of restricted stock units received in lieu of a $30,000 quarterly cash retainer under the company’s Non-Employee Director Compensation Program.

Rhea-AI Summary

Cencora (COR) director Dennis M. Nally reported acquiring 104 shares of common stock on 11/01/2025. The shares were issued in lieu of a $35,000 quarterly cash retainer under the company’s Non-Employee Director Compensation Program, at a reported price of $337.81. Following this transaction, Nally beneficially owns 13,477 shares held directly.

Rhea-AI Summary

Cencora (COR) CEO and Director Robert P. Mauch reported insider transactions on 10/20/2025. He exercised 3,763 stock options at $86.09 per share and sold 5,097 common shares at $326.80 per share under a Rule 10b5-1 trading plan adopted on 11/15/2024.

Following these transactions, he directly owned 37,940 common shares. The non-qualified stock option had an exercise price of $86.09 and an expiration date of 11/13/2026, with the grant previously vesting in four equal installments.

Rhea-AI Summary

Elizabeth S. Campbell, Executive Vice President and director of Cencora, Inc. (COR), reported a sale of 1,886 shares of Cencora common stock on 10/01/2025 at a price of $313.28 per share. Following the transaction, the reporting person beneficially owned 12,824.141 shares. The Form 4 states the sale was executed under a Rule 10b5-1 trading plan adopted on 12/20/2024. The form is signed by Ms. Campbell on 10/03/2025.